Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2017 Nov 20;8:1551. doi: 10.3389/fimmu.2017.01551

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2017 Mensah, Roetynck, Kanteh, Bowyer, Ndaw, Oko, Bliss, Jagne, Cortese, Nicosia, Roberts, D’Alessio, Leroy, Faye, Kampmann, Cisse, Bojang, Gerry, Viebig, Lawrie, Clarke, Imoukhuede, Ewer, Hill and Afolabi.

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

PMC Copyright notice

Peak enzyme-linked immunospot (ELISpot) responses to multiple epitope string thrombospondin-related adhesion protein (ME-TRAP) at D63, 7 days post-MVA. (A) Peak responses from vaccinated infants expressed per million PBMC. (B) Lymphocyte counts per milliliter of blood at D63. (C) ELISpot responses expressed per ml of blood. LLD, lower limit of detection of the assay. Peak responses and cell counts were compared across groups using Kruskal–Wallis test with Dunn’s multiple comparison post-test, *p < 0.05. Lines and numbers indicate geometric mean.